← Back to Clinical Trials
Recruiting NCT07383363
Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy
Trial Parameters
Condition Autism Spectrum Disorder
Sponsor Muhammad Aamir Latif
Study Type INTERVENTIONAL
Phase N/A
Enrollment 64
Sex ALL
Min Age 3 Years
Max Age 12 Years
Start Date 2025-09-23
Completion 2026-03-22
Interventions
Vita 6Zinc sulfate
Brief Summary
The study seeks to fill the gaps in available local data regarding the diagnosis and its management, as multiple treatments are in practice. Therefore, the study aimed at the comparison of efficacy and safety of Vita 6 versus zinc along with applied behavioral therapy in the management of autism spectrum disorder in children aged 3-14 years.
Eligibility Criteria
Inclusion Criteria: * Children of any gender * Aged 3-12 years * Newly diagnosed patients of autism spectrum disorder following the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria * Not taking any treatment Exclusion Criteria: * With any of psychiatric disorder * With any of movement disorder